XML 40 R25.htm IDEA: XBRL DOCUMENT
v3.20.4

Derivative Financial Instruments Derivative Financial Instruments | 12 Months Ended
--- | ---
Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Derivative Financial Instruments | Derivative Financial Instruments The Company uses derivatives to facilitate cross-currency corporate payments by writing derivatives to customers within its cross-border solution. The Company writes derivatives, primarily foreign currency forward contracts, option contracts, and swaps, mostly with small and medium size enterprises that are customers and derives a currency spread from this activity. Derivative transactions associated with the Company's cross-border solution include: •Forward contracts, which are commitments to buy or sell at a future date a currency at a contract price and will be settled in cash. •Option contracts, which gives the purchaser, the right, but not the obligation to buy or sell within a specified time a currency at a contracted price that may be settled in cash. •Swap contracts, which are commitments to settlement in cash at a future date or dates, usually on an overnight basis. The credit risk inherent in derivative agreements represents the possibility that a loss may occur from the nonperformance of a counterparty to the agreements. Concentrations of credit and performance risk may exist with counterparties, which includes customers and banking partners, as we are engaged in similar activities with similar economic characteristics related to fluctuations in foreign currency rates. The Company performs a review of the credit risk of these counterparties at the inception of the contract and on an ongoing basis. The Company also monitors the concentration of its contracts with any individual counterparty against limits at the individual counterparty level. The Company anticipates that the counterparties will be able to fully satisfy their obligations under the agreements, but takes action when doubt arises about the counterparties' ability to perform. These actions may include requiring customers to post or increase collateral, and for all counterparties, if the counterparty does not perform under the term of the contract, the contract may be terminated. The Company does not designate any of its foreign exchange derivatives as hedging instruments in accordance with ASC 815. For derivatives accounted for as hedging instruments, the Company formally designates and documents, at inception, the financial instrument as a hedge of a specific underlying exposure, the risk management objective and the strategy for undertaking the hedge transaction. The Company formally assesses, both at the inception and at least quarterly thereafter, whether the financial instruments used in hedging transactions are effective at offsetting changes in cash flows of the related underlying exposures. Any ineffective portion of a financial instrument's change in fair value is immediately recognized in earnings. The aggregate equivalent U.S. dollar notional amount of foreign exchange derivative customer contracts held by the Company as of December 31, 2020 and 2019 (in millions) is presented in the table below.
| Notional
| 2020 |  | 2019
Foreign exchange contracts: |  |  |
Swaps | $ | 684.5 |  |  | $ | 599.5 |
Futures, forwards and spot | 5,467.8 |  |  | 3,017.1 |
Written options | 5,578.1 |  |  | 6,393.9 |
Purchased options | 5,195.0 |  |  | 5,830.8 |
Total | $ | 16,925.4 |  |  | $ | 15,841.3 |
The majority of customer foreign exchange contracts are written in currencies such as the U.S. dollar, Canadian dollar, British pound, euro and Australian dollar. The following table summarizes the fair value of derivatives reported in the Consolidated Balance Sheets as of December 31, 2020 and 2019 (in millions):
December 31, 2020 | Fair Value, Gross |  | Fair Value, Net |  |
| Derivative Assets |  | Derivative Liabilities |  | Derivative Assets |  | Derivative Liabilities |  |  |  |
Derivatives - undesignated: |  |  |  |  |  |  |  |  |  |  |
Foreign exchange contracts | $ | 326.1 |  |  | $ | 310.5 |  |  | $ | 155.8 |  |  | $ | 140.3 |  |  |  |  |
Less: Cash collateral | 18.2 |  |  | 38.6 |  |  | 18.2 |  |  | 38.6 |  |  |  |  |
Total net derivative assets and liabilities | $ | 307.9 |  |  | $ | 271.9 |  |  | $ | 137.6 |  |  | $ | 101.7 |  |  |  |  |
December 31, 2019 | Fair Value, Gross |  | Fair Value, Net
| Derivative Assets |  | Derivative Liabilities |  | Derivative Assets |  | Derivative Liabilities
Derivatives - undesignated: |  |  |  |  |  |  |
Foreign exchange contracts | 114.9 |  |  | 103.8 |  |  | 72.1 |  |  | 60.9 |
Less: Cash collateral | 6.1 |  |  | 25.6 |  |  | 6.1 |  |  | 25.6 |
Total net derivative assets and liabilities | $ | 108.8 |  |  | $ | 78.2 |  |  | $ | 66.0 |  |  | $ | 35.3 |
The fair values of derivative assets and liabilities associated with contracts, which include netting terms that the Company believes to be enforceable, have been recorded net within the Consolidated Balance Sheets. The Company receives cash from customers as collateral for trade exposures, which is recorded within cash and cash equivalents and customer deposits in the Consolidated Balance Sheets. The customer has the right to recall their collateral in the event exposures move in their favor, they perform on all outstanding contracts and have no outstanding amounts due to the Company, or they cease to do business with the Company. The Company has trading lines with several banks, most of which require collateral to be posted if certain MTM thresholds are exceeded. Cash collateral posted with banks is recorded within restricted cash and can be recalled in the event that exposures move in the company’s favor or move below the collateral posting thresholds. The Company does not offset fair value amounts recognized for the right to reclaim cash collateral or the obligation to return cash collateral. At December 31, 2020, $139.3 million derivative assets and $127.7 million derivative liabilities were recorded in other current assets and other current liabilities, respectively, and $16.6 million derivative assets and $12.5 million derivative liabilities were recorded in other long term assets and other long term liabilities, respectively, in the Consolidated Balance Sheet. At December 31, 2019, $72.1 million derivative assets and $60.9 million derivative liabilities were recorded in other current assets and other current liabilities, respectively, in the Consolidated Balance Sheet. The Company receives cash from customers as collateral for trade exposures, which is recorded within restricted cash and customer deposits in the Consolidated Balance Sheet. Cash Flow Hedges On January 22, 2019, the Company entered into three interest rate swap cash flow contracts (the "swap contracts"). The objective of these swap contracts is to reduce the variability of cash flows in the previously unhedged interest payments associated with $2.0 billion of variable rate debt, the sole source of which is due to changes in the LIBOR benchmark interest rate. As of December 31, 2020, the Company had the following outstanding interest rate derivatives that qualify as hedging instruments and are designated as cash flow hedges of interest rate risk (in millions):
|  | Notional Amount as of |  | Fixed Rates |  | Maturity Date
|  | December 31, 2020 |
Interest Rate Derivative: |  |  |  |  |  |
Interest Rate Swap |  | $ | 1,000 |  |  | 2.56% |  | 1/31/2022
Interest Rate Swap |  | 500 |  |  | 2.56% |  | 1/31/2023
Interest Rate Swap |  | 500 |  |  | 2.55% |  | 12/19/2023
For each of these swap contracts, the Company pays a fixed monthly rate and receives one month LIBOR. The table below presents the fair value of the Company’s interest rate swap contracts, as well as their classification on the Consolidated Balance Sheets, as of December 31, 2020 and 2019 (in millions). See Note 4 for additional information on the fair value of the Company’s swap contracts.
|  | Balance Sheet Location |  | December 31, 2020 |  | December 31, 2019
Derivatives designated as cash flow hedges: |  |  |  |  |  |
Swap contracts |  | Other current liabilities |  | $ | (49.3) |  |  | $ | — |
Swap contracts |  | Other noncurrent liabilities |  | $ | (38.6) |  |  | $ | (56.4) |
The table below displays the effect of the Company’s derivative financial instruments in the Consolidated Statements of Income and other comprehensive loss for the twelve months ended December 31, 2020 and 2019 (in millions):
|  | 2020 |  | 2019
Interest Rate Swaps: |  |  |  |
Amount of loss recognized in other comprehensive income (loss) on derivatives, net of tax of $8.0 million and $20.3 million for 2020 and 2019, respectively |  | $62.7 |  | $42.8
Amount of loss reclassified from accumulated other comprehensive loss into interest expense |  | $39.3 |  | $5.8
The estimated net amount of the existing losses expected to be reclassified into earnings within the next 12 months is approximately $49.3 million at December 31, 2020.

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -URI http://asc.fasb.org/topic&trid=2229140 + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration